Ms. Beth Rogozinski

Beth Rogozinski is a serial entrepreneur, technology professional, and business strategist who has spent the last several years focused on digital medicine. Beth has worked in hardware, software and services at such top firms as Silicon Graphics, Macromedia, and the digital agency Circle and has also founded games and apps companies including Signal 2 Productions, Match Factor and D2S Games.

She has produced and published more than 30 games and apps, including over a dozen apps for health and wellness. At Pear Therapeutics, Beth served as Chief Product Officer and led the development of Pear’s first clinical product, reSET, and the product team submission of the De Novo 510(k) to the FDA which was cleared by the FDA in 2017 as the first ever prescription digital therapeutic.

Beth is an advisor to many start-ups and accelerators and has consulted with local and international venture groups around digital health investments. Beth serves on the Biotechnology Innovation Organization’s educational programs committees for Digital Health and chairs the program for Brain Health. She has written and published on digital therapeutics and tech innovations and is a frequent speaker at technology and healthcare events.